Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

Saved in:

Bibliographic Details
Published in	Leukemia Vol. 32; no. 8; pp. 1869 - 1873
Main Authors	Gentile, Massimo, Shanafelt, Tait D., Reda, Gianluigi, Mauro, Francesca Romana, Zirlik, Katja, Ciolli, Stefania, Laurenti, Luca, Del Principe, Maria Ilaria, Rossi, Davide, Di Renzo, Nicola, Molica, Stefano, Angrilli, Francesco, Coscia, Marta, Chiarenza, Annalisa, Giordano, Annamaria, Cutrona, Giovanna, Chaffee, Kari G., Parikh, Sameer A., Uccello, Giuseppina, Innocenti, Idanna, Tripepi, Giovanni, D’Arrigo, Graziella, Vigna, Ernesto, Recchia, Anna Grazia, Herishanu, Yair, Shvidel, Lev, Tadmor, Tamar, Cortelezzi, Agostino, Del Poeta, Giovanni, Gaidano, Gianluca, Di Raimondo, Francesco, Neri, Antonino, Ferrarini, Manlio, Foà, Robin, Polliack, Aaron, Morabito, Fortunato
Format	Journal Article
Language	English
Published	London Nature Publishing Group UK 01.08.2018 Nature Publishing Group
Subjects	631/67/1059/99 692/699/1541/1990/283/1895 Brief Communication Cancer Research Chronic lymphocytic leukemia Critical Care Medicine Hematology Immunotherapy Intensive Internal Medicine Leukemia Lymphatic leukemia Medicine Medicine & Public Health Monoclonal antibodies Oncology Rituximab Targeted cancer therapy
Online Access	Get full text
ISSN	0887-6924 1476-5551 1476-5551
DOI	10.1038/s41375-018-0100-6

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3
ISSN:	0887-6924 1476-5551 1476-5551
DOI:	10.1038/s41375-018-0100-6